Natriuretic peptides as prognostic and diagnostic markers in Chagas' disease

Ana M Puyó1, Jorge Scaglione, Sergio Auger

  • 1Cátedra de Anatomía Macro y Microscópica, Universidad de Buenos Aires, Junín 956, (1113) Buenos Aires, Argentina.

Regulatory Peptides
|April 20, 2005
PubMed

Insights

Atrial natriuretic factor (ANF) may indicate heart damage in Chagas' disease. Elevated ANF levels in rats and patients suggest its potential as a prognostic marker for cardiac compromise and survival.

Area of Science:

  • Cardiology
  • Parasitology
  • Endocrinology

Background:

  • Chagas' disease, caused by Trypanosom cruzi (T. cruzi), frequently leads to myocarditis and chronic cardiomyopathy.
  • The cardiac inflammatory response in Chagas' disease may involve ischemia, parasite invasion, and autoimmune processes.
  • Atrial natriuretic factor (ANF) is a hormone released by the heart in response to wall tension.

Purpose of the Study:

  • To review current knowledge on ANF in Chagas' disease.
  • To investigate the relationship between plasma ANF levels and the development of chagasic cardiomyopathy in infected rats.
  • To assess the evolution of plasma ANF in chagasic patients across different disease stages and its prognostic value.

Main Methods:

  • Experimental induction of Chagas' disease in rats to monitor cardiac changes and plasma ANF.
  • Longitudinal study of plasma ANF levels in chagasic patients (asymptomatic, conduction defects, chronic heart failure).
  • Correlation analysis of ANF levels with cardiac compromise and patient survival.

Main Results:

  • Elevated plasma ANF levels in infected rats correlated with myocardial inflammation and cardiac dysfunction.
  • In patients, plasma ANF levels reflected disease progression, from asymptomatic stages to chronic heart failure.
  • ANF demonstrated potential as a sensitive marker for detecting cardiac impairment and predicting survival in Chagas' disease.

Conclusions:

  • Plasma ANF levels are elevated in experimental Chagas' disease, reflecting myocardial inflammation and cardiac dysfunction.
  • ANF serves as a sensitive biomarker for assessing cardiac compromise and predicting survival in chagasic patients.
  • ANF may be a valuable prognostic tool for monitoring disease progression and guiding patient management in Chagas' disease.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...